- Home
- BNGO vs PYPD Comparison
BNGO vs PYPD Comparison
Compare BNGO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- PYPD
- Stock Information
- Founded
- BNGO 2003
- PYPD 2008
- Country
- BNGO United States
- PYPD Israel
- Employees
- BNGO N/A
- PYPD N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- PYPD Medical/Dental Instruments
- Sector
- BNGO Industrials
- PYPD Health Care
- Exchange
- BNGO Nasdaq
- PYPD Nasdaq
- Market Cap
- BNGO 28.7M
- PYPD 24.1M
- IPO Year
- BNGO 2018
- PYPD 2020
- Fundamental
- Price
- BNGO $0.26
- PYPD $3.40
- Analyst Decision
- BNGO Hold
- PYPD Strong Buy
- Analyst Count
- BNGO 3
- PYPD 2
- Target Price
- BNGO $1.00
- PYPD $12.00
- AVG Volume (30 Days)
- BNGO 3.4M
- PYPD 7.6K
- Earning Date
- BNGO 11-13-2024
- PYPD 11-13-2024
- Dividend Yield
- BNGO N/A
- PYPD N/A
- EPS Growth
- BNGO N/A
- PYPD N/A
- EPS
- BNGO N/A
- PYPD N/A
- Revenue
- BNGO $36,579,000.00
- PYPD N/A
- Revenue This Year
- BNGO N/A
- PYPD N/A
- Revenue Next Year
- BNGO $21.35
- PYPD N/A
- P/E Ratio
- BNGO N/A
- PYPD N/A
- Revenue Growth
- BNGO 16.08
- PYPD N/A
- 52 Week Low
- BNGO $0.24
- PYPD $2.95
- 52 Week High
- BNGO $2.27
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- BNGO 33.68
- PYPD 48.44
- Support Level
- BNGO $0.27
- PYPD $3.33
- Resistance Level
- BNGO $0.38
- PYPD $3.58
- Average True Range (ATR)
- BNGO 0.03
- PYPD 0.25
- MACD
- BNGO 0.00
- PYPD 0.01
- Stochastic Oscillator
- BNGO 11.36
- PYPD 38.46
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.